Target intelligence / Profile preview

Soluble antigens and cytokines

Molecular classification
Cytokine, Other
01

Overview

Soluble antigens and cytokines are a diverse group of extracellular proteins that facilitate intercellular communication and immune system regulation. Cytokines, including interleukins, chemokines, and interferons, serve as signaling molecules that bind to specific cell-surface receptors to initiate biological responses such as inflammation, cell proliferation, and immune cell activation (StatPearls, 2023). Soluble antigens are circulating molecules, often derived from pathogens or tumor cells, that can be recognized by the immune system or targeted by therapeutic antibodies (PubMed, 1988). In pathological states like rheumatoid arthritis or cytokine storm syndromes, the overproduction of these factors leads to tissue damage and systemic inflammation. Many blockbuster drugs, such as TNF inhibitors and IL-1 beta antagonists, work by binding and neutralizing these soluble mediators to prevent them from activating their cognate receptors (Nature Reviews Drug Discovery, 2018). Because this term refers to a broad functional class rather than a single molecular entity, it is classified as a category of targets rather than a specific therapeutic target. Targeting these molecules requires high specificity to avoid broad immunosuppression while effectively dampening the specific pathway driving the disease. Monitoring levels of these soluble factors often serves as a diagnostic or prognostic tool in clinical settings.

Other names
Soluble mediatorsCirculating cytokinesExtracellular antigensSoluble factors
02

Mechanism of action

Neutralization of soluble signaling molecules (cytokines or ligands) to prevent their interaction with cell-surface receptors, thereby inhibiting downstream signaling pathways.

03

Biological functions

Immune responseSignal transductionOther
04

Disease associations

InflammationCancerInfectionOther
05

Safety considerations

Increased risk of serious infectionsImmunogenicity and anti-drug antibodiesCytokine release syndromeInjection site or infusion reactionsPotential for malignancy
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Serum cytokine levels (e.g., IL-6, TNF-alpha)Soluble CD14Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Soluble antigens and cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soluble antigens and cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call